BMS-964210 / BMS - LARVOL DELTA

Efficacy Study of Chinese Medicine Plus EGFR-TKI Versus EGFR-TKI in Advanced Pulmonary Adenocarcinoma (clinicaltrials.gov) - P=N/A; N=470; Enrolling by invitation; Sponsor: Shanghai University of Traditional Chinese Medicine; Trial primary completion date: Jun 2014 ->Oct 2014

Trial primary completion date • Biosimilar • Non Small Cell Lung Cancer • Oncology

Laboratory Treated T Cells in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphoma, or Acute Lymphoblastic Leukemia (clinicaltrials.gov) - P1/2; N=104; Recruiting; Sponsor: Fred Hutchinson Cancer Research Center; N=54 -> 104

Enrollment change • Acute Lymphocytic Leukemia • Biosimilar • Hematological Malignancies • Immunology • Leukemia • Non-Hodgkin’s Lymphoma • Oncology